HK1203815A1 - Pharmaceutical compositions and methods for their preparation - Google Patents
Pharmaceutical compositions and methods for their preparationInfo
- Publication number
- HK1203815A1 HK1203815A1 HK15104271.5A HK15104271A HK1203815A1 HK 1203815 A1 HK1203815 A1 HK 1203815A1 HK 15104271 A HK15104271 A HK 15104271A HK 1203815 A1 HK1203815 A1 HK 1203815A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- methods
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261585920P | 2012-01-12 | 2012-01-12 | |
PCT/US2013/021267 WO2013106732A1 (fr) | 2012-01-12 | 2013-01-11 | Compositions pharmaceutiques et procédés pour leur préparation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203815A1 true HK1203815A1 (en) | 2015-11-06 |
Family
ID=47628451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104271.5A HK1203815A1 (en) | 2012-01-12 | 2015-05-05 | Pharmaceutical compositions and methods for their preparation |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150004239A1 (fr) |
EP (1) | EP2802315A1 (fr) |
JP (1) | JP2015503624A (fr) |
AU (1) | AU2013207825A1 (fr) |
CA (1) | CA2860995A1 (fr) |
HK (1) | HK1203815A1 (fr) |
WO (1) | WO2013106732A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230130175A (ko) | 2014-12-26 | 2023-09-11 | 에모리 유니버시티 | N4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도 |
US11357742B2 (en) | 2015-12-14 | 2022-06-14 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
EP3389634B1 (fr) | 2015-12-14 | 2021-10-06 | X4 Pharmaceuticals, Inc. | Méthodes de traitement du cancer |
JP7055380B2 (ja) | 2015-12-22 | 2022-04-18 | エックス4 ファーマシューティカルズ, インコーポレイテッド | 免疫不全疾患を処置するための方法 |
CA3019394A1 (fr) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methodes de traitement du cancer |
JP7084624B2 (ja) | 2016-06-21 | 2022-06-15 | エックス4 ファーマシューティカルズ, インコーポレイテッド | Cxcr4阻害剤およびその使用 |
EP3808748A1 (fr) | 2016-06-21 | 2021-04-21 | X4 Pharmaceuticals, Inc. | Piperidines substutues comme inhibiteurs de cxcr4 |
EP3472129A4 (fr) | 2016-06-21 | 2019-12-04 | X4 Pharmaceuticals, Inc. | Inhibiteurs de cxcr4 et leurs utilisations |
CN118477088A (zh) | 2017-12-07 | 2024-08-13 | 埃默里大学 | N4-羟基胞苷及衍生物和与其相关的抗病毒用途 |
US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB453061A (en) | 1935-03-23 | 1936-09-04 | Charles Howard Twigg | Improvements in and relating to gas heated geysers and water heaters |
DE10153078A1 (de) | 2001-10-30 | 2003-05-22 | Degussa | Verwendung von Granulaten auf Basis von pyrogen hergestelltem Siliciumdioxid in pharmazeutischen Zusammensetzungen |
SI2049506T2 (sl) | 2006-07-07 | 2024-07-31 | Gilead Sciences, Inc. | Modulatorji farmakokinetičnih lastnosti terapevtikov |
EP2487168A1 (fr) * | 2007-02-23 | 2012-08-15 | Gilead Sciences, Inc. | Modulateurs de propriétés pharmacocinétiques d'agents thérapeutiques |
WO2009088719A1 (fr) * | 2008-01-04 | 2009-07-16 | Gilead Sciences, Inc. | Inhibiteurs du cytrochrome p450 |
WO2009135179A2 (fr) | 2008-05-02 | 2009-11-05 | Gilead Sciences, Inc. | Utilisation de particules supports solides pour améliorer l'aptitude au traitement d'un agent pharmaceutique |
-
2013
- 2013-01-11 CA CA2860995A patent/CA2860995A1/fr not_active Abandoned
- 2013-01-11 WO PCT/US2013/021267 patent/WO2013106732A1/fr active Application Filing
- 2013-01-11 AU AU2013207825A patent/AU2013207825A1/en not_active Abandoned
- 2013-01-11 US US14/371,716 patent/US20150004239A1/en not_active Abandoned
- 2013-01-11 JP JP2014552338A patent/JP2015503624A/ja not_active Withdrawn
- 2013-01-11 EP EP13701888.3A patent/EP2802315A1/fr not_active Withdrawn
-
2015
- 2015-05-05 HK HK15104271.5A patent/HK1203815A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013106732A1 (fr) | 2013-07-18 |
AU2013207825A1 (en) | 2014-08-28 |
EP2802315A1 (fr) | 2014-11-19 |
JP2015503624A (ja) | 2015-02-02 |
US20150004239A1 (en) | 2015-01-01 |
CA2860995A1 (fr) | 2013-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
IL252566A0 (en) | Pharmacy preparations and methods | |
IL236024A (en) | The history of benzimidazole-proline and its pharmaceutical preparations | |
HK1209638A1 (en) | Pharmaceutical compositions | |
PL3181122T3 (pl) | Kompozycja farmaceutyczna dazatynibu | |
HK1195793A1 (zh) | 結合藥物組合物及其用途 | |
IL237839A0 (en) | History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them | |
ZA201501930B (en) | Pharmaceutical composition | |
IL235414A (en) | The history of pyrolotriazinone, their preparation and their pharmaceutical preparations | |
HK1203815A1 (en) | Pharmaceutical compositions and methods for their preparation | |
EP2832730A4 (fr) | Composition pharmaceutique contenant du mirabegron | |
HK1205146A1 (en) | Pharmaceutical formulation | |
EP2775831A4 (fr) | Compositions pharmaceutiques et leurs utilisations | |
GB2504390B (en) | Nutraceutical and pharmaceutical composition | |
EP2665480A4 (fr) | Compositions pharmaceutiques et leurs procédés de fabrication et d'utilisation | |
ZA201502987B (en) | Pharmaceutical composition | |
GB201208315D0 (en) | Pharmaceutical methods and compositions | |
IL238826A0 (en) | History of imidazole - piperidinyl, their preparation and pharmaceutical preparations containing them | |
EP2897590A4 (fr) | Composition pharmaceutique | |
GB201211153D0 (en) | Pharmaceutical compositions | |
IL234614B (en) | Pharmaceutical composition and preparation method thereof | |
IL236870A0 (en) | The history of hydroxystatin, their preparation and pharmaceutical preparations containing them | |
EP2851078A4 (fr) | Composition pharmaceutique | |
IL238075A0 (en) | pharmaceutical preparations | |
ZA201400751B (en) | Pharmaceutical composition |